Luminex xMAP® Technology is used in both research and clinical diagnostics testing and has appeared in over 12,000 peer-reviewed publications. Numerous laboratories around the world use Luminex for a variety of research areas.
The following institutions have published extensively with Luminex technology and a brief description of their works is included.
- University of Pittsburgh – Luminex is used in both the cancer research core facility and in transplant diagnostics. This institution has published over 200 peer-reviewed papers using xMAP Technology. For research applications, Dr. Anna Lokshin runs the Luminex core facility and has co-authored over 30 publications utilizing Luminex. Luminex is also used at University of Pittsburgh for histocompatibility in tissue transplantation.
- University of Washington in Seattle uses xMAP to study biomarkers in cerebrospinal fluid that are involved in neurodegenerative diseases such as Parkinson’s Disease and Alzheimer’s Disease.
- Harvard University has published over 100 scientific publications using xMAP. Harvard has made unique assays using the open xMAP Technology, including screening of receptor tyrosine kinases, cytokine assays, novel gene expression assays, and genotyping assays.
- Duke University uses xMAP Technology for custom assays at the Duke Human Vaccine Institute. They work with researchers in other institutions to study HIV vaccines in development, as well using more commonly encountered multiplex cytokine assays.
- University of Michigan has published over 90 papers based on xMAP data. Labs there study mechanisms of immune response in arthritis, cancer and other diseases.
Researchers continue to use Luminex technology for a multitude of research areas and develop their own novel assays using the flexible and open features. For a full library of Luminex publications visit https://lmnxja.acscreativedev.com/publications/.
What has your lab used Luminex xMAP Technology for lately?